A Study to Investigate the Safety and Efficacy of Undiluted Intravenous Infusion of I.V.-Hepabig Inj.
A Study to Investigate the Safety and Efficacy of Undiluted Intravenous Infusion of I.V.-Hepabig Inj.
Recruiting · NCT05686759 · Registry updated 2025-06-25Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Study to Investigate the Safety and Efficacy of Undiluted Intravenous Infusion of I.V.-Hepabig Inj. | Blood-Borne Infections, DNA Virus Infections, Digestive System Diseases, Hepadnaviridae infectious disease, Infections, hepatitis, hepatitis B virus infection, infectious disease, liver disorder, viral hepatitis, viral infectious disease | Recruiting | Phase 3 | 2025-06-25 | NCT05686759 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| GC Biopharma Corp | 9 |
8 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Ajou University Medical Center | Suwon | South Korea | 4 |
| Asan Medical Center | Seoul | South Korea | 22 |
| Chungnam National University Hospital | Daejeon | South Korea | 38 |
| Inje University Haeundae Paik Hospital | Busan | South Korea | 48 |
| National Cancer Center | Goyang-si | South Korea | 32 |
| Samsung Medical Center | Seoul | South Korea | 375 |
| Seoul National University Hospital | Seoul | South Korea | 393 |
| Severance Hospital | Seoul | South Korea | 81 |